Literature DB >> 16706553

Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis.

Vanessa R Anderson1, Caroline M Perry.   

Abstract

Pentosan polysulfate (pentosan polysulfate sodium; ELMIRON), a heparin-like, sulfated polysaccharide, is used to manage bladder pain and discomfort in adults with interstitial cystitis (IC). Preliminary clinical models suggest that pentosan polysulfate repairs damaged glycosaminoglycan (GAG) layers lining the urothelium and in vitro data suggest it may provide an anti-inflammatory effect in patients with IC. Pentosan polysulfate shows beneficial effects in a proportion of patients with IC in terms of the improvement of a patient's overall condition and the relief of pain, and it is a generally well tolerated therapy. It is the only US FDA-approved oral treatment for the relief of bladder pain or discomfort associated with IC, and data support its role as an important option in the treatment of patients with IC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16706553     DOI: 10.2165/00003495-200666060-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  38 in total

Review 1.  Prostatitis, interstitial cystitis, chronic pelvic pain, and urethral syndrome share a common pathophysiology: lower urinary dysfunctional epithelium and potassium recycling.

Authors:  C Lowell Parsons
Journal:  Urology       Date:  2003-12       Impact factor: 2.649

2.  Prevention of acrolein-induced bladder injury by pentosanpolysulfate.

Authors:  S J Kalota; P C Stein; C L Parsons
Journal:  J Urol       Date:  1992-07       Impact factor: 7.450

Review 3.  Interstitial cystitis.

Authors:  D O Selo-Ojeme; J L Onwude
Journal:  J Obstet Gynaecol       Date:  2004-04       Impact factor: 1.246

4.  Pentosan induced cerebral sagittal sinus thrombosis: a variant of heparin induced thrombocytopenia.

Authors:  L Rice; D Kennedy; A Veach
Journal:  J Urol       Date:  1998-12       Impact factor: 7.450

5.  The oral bioavailability of pentosan polysulphate sodium in healthy volunteers.

Authors:  R A Faaij; N Srivastava; J M van Griensven; R C Schoemaker; C Kluft; J Burggraaf; A F Cohen
Journal:  Eur J Clin Pharmacol       Date:  1999-02       Impact factor: 2.953

6.  Safety and efficacy of concurrent application of oral pentosan polysulfate and subcutaneous low-dose heparin for patients with interstitial cystitis.

Authors:  Arndt van Ophoven; Achim Heinecke; Lothar Hertle
Journal:  Urology       Date:  2005-10       Impact factor: 2.649

7.  A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate.

Authors:  C L Parsons; G Benson; S J Childs; P Hanno; G R Sant; G Webster
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

8.  Massive bleeding on a bladder protectant: a case report of pentosan polysulfate sodium-induced coagulopathy.

Authors:  Sharlene Gill; Sheldon C Naiman; Abeed Jamal; Linda M Vickars
Journal:  Arch Intern Med       Date:  2002-07-22

9.  A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis.

Authors:  G R Sant; K J Propert; P M Hanno; D Burks; D Culkin; A C Diokno; C Hardy; J R Landis; R Mayer; R Madigan; E M Messing; K Peters; T C Theoharides; J Warren; A J Wein; W Steers; J W Kusek; L M Nyberg
Journal:  J Urol       Date:  2003-09       Impact factor: 7.450

Review 10.  Treatment of interstitial cystitis.

Authors:  Michael B Chancellor; Naoki Yoshimura
Journal:  Urology       Date:  2004-03       Impact factor: 2.649

View more
  18 in total

Review 1.  Treatment of bladder pain syndrome and interstitial cystitis: a systematic review.

Authors:  Carolina Pazin; Andréia Moreira de Souza Mitidieri; Ana Paula Moreira Silva; Maria Beatriz Ferreira Gurian; Omero Benedicto Poli-Neto; Julio Cesar Rosa-E-Silva
Journal:  Int Urogynecol J       Date:  2015-08-14       Impact factor: 2.894

Review 2.  Minimally invasive therapies for chronic pelvic pain syndrome.

Authors:  Salim A Wehbe; Jennifer Y Fariello; Kristene Whitmore
Journal:  Curr Urol Rep       Date:  2010-07       Impact factor: 3.092

3.  Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities In Vitro and In Vivo.

Authors:  Guangyong Ma; Jun-Ichirou Yasunaga; Koichi Ohshima; Tadashi Matsumoto; Masao Matsuoka
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

4.  Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study.

Authors:  Julia B Hennermann; Seyfullah Gökce; Alexander Solyom; Eugen Mengel; Edward H Schuchman; Calogera M Simonaro
Journal:  J Inherit Metab Dis       Date:  2016-09-02       Impact factor: 4.982

5.  Intravesical instillation of pentosan polysulfate encapsulated in a liposome nanocarrier for interstitial cystitis.

Authors:  Elliot B Lander; Jackie R See
Journal:  Am J Clin Exp Urol       Date:  2014-07-12

6.  Long-term efficacy and tolerability of pentosan polysulphate sodium in the treatment of bladder pain syndrome.

Authors:  Ali A Al-Zahrani; Jerzy B Gajewski
Journal:  Can Urol Assoc J       Date:  2011-04       Impact factor: 1.862

Review 7.  Treatment approaches for painful bladder syndrome/interstitial cystitis.

Authors:  Theoharis C Theoharides
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Effects of low-molecular-weight polyguluronate sulfate on experimental urolithiasis in rats.

Authors:  Xia Zhao; Guangli Yu; Nan Yue; Huashi Guan
Journal:  Urol Res       Date:  2007-10-11

9.  Managing Interstitial Cystitis/Bladder Pain Syndrome in Older Adults.

Authors:  Alyssa Gracely; Anne P Cameron
Journal:  Drugs Aging       Date:  2020-10-23       Impact factor: 3.923

10.  Pharmacological profiles of animal- and nonanimal-derived sulfated polysaccharides--comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguinea.

Authors:  Inken Groth; Niels Grünewald; Susanne Alban
Journal:  Glycobiology       Date:  2008-12-23       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.